Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hanaa Awad Elsamadony has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A comprehensive pathological and molecular investigation of viral co-infections in ducks in Egypt

    by Rania I. Mohamed, Samah M. Mosad, Hanaa S. Ali, Wejdan Oudah Albalawi, Hanaa A. Elsamadony, Neven M. Ramzy, Alaa S. Saad, Deema Fallatah, Lina Jamil M. Abdel-Hafez, Ashraf Albrakati, et al.

    Introduction: Duck production in Egypt plays a significant role in the poultry sector. However, viral infections, such as avian influenza virus (AIV), Newcastle disease virus (NDV), and duck hepatitis A virus (DHAV), pose a significant threat to ducks, leading to substantial economic losses. Despite their impact, data on these duck pathogens in Egypt remain limited.Methods: In this study, 200 samples from various organs were collected from 20 commercial duck farms and pooled into 20 working samples. Samples of brain, liver, spleen, trachea, and lung were analyzed to detect DHAV, NDV, and H5 and H9 AIV using reverse transcriptase polymerase chain reaction (RT-PCR); then, positive samples were subjected for sequencing. Samples from the same organs were also subjected for histopathological examination.Results: Interestingly, the RT-PCR detected DHAV, NDV, and H9-AIV, and mixed viral infections were confirmed in some farms. The phylogenetic analysis of DHAV 3D gene revealed that both DHAV-1 and DHAV-3 genotypes are circulating in Egyptian duckling with most tested samples containing DHAV-3 genotype, considered the vaccine used in Egypt contains DHAV-1 strain only. All detected NDV strains in this study are clustered in Genotype VII.1.1 with F0 cleavage site (RRQKR ↓ F) of velogenic NDV. On the other hand, our studied H9-AIV strains are aligned in H9.4.1.1 sub-lineage with other Egyptian field and vaccine seed strains. Local Egyptian vaccine seed strains were found closely related to our isolates than imported vaccines. H9.4.1 strains displayed HA0 protein cleavage site motif PARSSR↓GLF of LPAI. All the aligned Egyptian H9-AIV field and local vaccine strains have 168 N, 191H, 197 T, 224 L, and 234 L amino residues, indicating that these viruses had the characteristic of receptor specificity like that of human influenza virus increasing the zoonotic risk of such virus. Histopathologically, animals showed characteristic lesions in various organs coherent to the infection by these mentioned pathogens.Conclusion: Collectively, the study provided novel information about viral infections linked to neurological diseases of ducks in Egypt and concluded that local DHAV vaccine needs to be modified to contain both DHAV-1 and DHAV-3 strains.


  • Open Access

    Genetic Differences and Pathogenicity of Chicken Anemia Virus Strains in Broiler’s Baby Chicks

    by Hanaa Elsamadony, Hoda M Mekky, Hanaa Fedawy, Dalia Sedeek, Ahmed El-Shemy, Aalaa Saad

    This study aims to molecular characterization of the Chicken Anemia Virus (CAV) in young broilers in the Giza governorate, Egypt in 2021, assess the genetic diversity among the proliferating viruses, and vaccine strains, and evaluate their pathogenicity to improve viral management. Viral protein 2 (VP2) gene was amplified and subsequently conducted molecular-level characterization. In five out of the ten flocks sampled CAV was detected. Furthermore, the examination of the phylogenetic connections performed according to the sequences of the VP2 gene demonstrated the classification of the observed field strains within genogroups I, II, and IIIb. In silico analysis was performed on Cux-1 and the detected five strains to investigate the secondary structures of VP2 proteins. The findings indicated a significant resemblance in the distribution and quantity of α-helical and β-strand topologies. To assess the pathogenicity of the virus, two isolates from genotype III (MZ574096.1) and genotype II (MZ477000.1) were administered intramuscularly to sets of day-old, specific pathogen-free chicks. At 28 days following inoculation, the Red Blood Corpuscle count (X106µL) was (1.4 ±0.39 and 1.8± 0.12).


  • Open Access

    Molecular and pathological screening of the current circulation of fowlpox and pigeon pox virus in backyard birds

    by Rania I. Mohamed, Hanaa A. Elsamadony, Rana A. Alghamdi, Asmaa Lbrahim Abdelaziz Zin Eldin, Ahmed El-Shemy, Sameh Abdel-Moez Amer, Safia M.A. Bahshwan, Mohamed T. El-Saadony, Hemat S. El-Sayed, Khaled A. El-Tarabily, et al.


  • Open Access

    Isolation, genotyping, and sub-genotyping of Newcastle disease virus from commercial broiler chickens in Northern Egypt

    by N Ramzy, H Elsamadony, H Mekky, H Fedawy, A Saad

    The governments seek to take care of livestock; it plays a significant role in the national economy because of the nutritional and economic importance of poultry protein. In poultry, viral diseases, including the Newcastle virus, are considered among the causes of profitable losses in poultry, which directly affect livestock and the general health of birds. Therefore, this research was conducted to follow up on the Newcastle disease virus recently circulating in commercial poultry farms in northern Egypt and compare the master amino acids that determine the velogeneity of the ND virus. In addition, this research will compare their relationship to the vaccines currently in use. A specific-pathogen-free chicken (EE-SPF) egg was used to isolate NDV from chicken farms. We then tested the inoculated allantoic fluids for NDV using the Hemagglutination Test and Hyper-Immune Serum against LaSota NDV. Furthermore, the F gene was molecularly characterized and sequenced. From 15 allantoic fluids that were positive for NDV, seven isolates (ON497007, ON497008, ON497010, ON497011, ON497012, and ON497013 and ON532692) out of 9 ND sequenced isolates clustered into sub-genotype VII.1.1 and the other 2 (ON497006 and ON497009) into sub-genotype XXI.1.1. All the isolates in this investigation carry the velogenic strain's characteristic velogenic motif 112RKQKR*F117. In conclusion, the circulating ND in vaccinated chicken flocks in Egypt genotype VII.1.1 and XXI.1.1. Moreover, there was a residual substitution between most isolates, and genotype VII vaccine strain (R/K), and autogenous vaccine strain (E/R) at position 78. These results are expected to help provide the latest characteristic information on NDV in northern Egypt.


  • Open Access

    Alpha-sitosterol: a new antiviral agent produced by Streptomyces misakiensis and its potential activity against Newcastle disease virus

    by Rewan Abdelaziz, Yasmine H. Tartor, Ahmed B. Barakat, Gamal El-Didamony, Marwa M. Gado, Mohamed Samir A. Zaki, Refaat A. Eid, Hanaa A. El-Samadony

    Background: Newcastle Disease Virus (NDV) causes severe economic losses in the poultry industry worldwide. Hence, this study aimed to discover a novel bioactive antiviral agent for controlling NDV. Streptomyces misakiensis was isolated from Egyptian soil and its secondary metabolites were identified using infrared spectroscopy (IR), gas chromatography–mass spectrometry (GC–MS), and nuclear magnetic resonance (NMR) spectroscopy. The inhibitory activity of bioactive metabolite against NDV were examined. Three experimental groups of 10-day-old specific pathogen-free embryonated chicken eggs (SPF-ECEs), including the bioactive metabolite control group, NDV control positive group, and α-sitosterol and NDV mixture-treated group were inoculated. Results: α-sitosterol (Ethyl-6-methylheptan-2-yl]-10,13-dimethyl-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol), a secondary metabolite of S. misakiensis, completely inhibited hemagglutination (HA) activity of the NDV strain. The HA activity of the NDV strain was 8 log2 and 9 log2 for 0.5 and 0.75% RBCs, respectively. The NDV HA activity for the two concentrations of RBCs was significantly (P < 0.0001) inhibited after α-sitosterol treatment. There was a significant (P < 0.0001) decrease in the log 2 of HA activity, with values of − 0.500 (75%, chicken RBCs) before inoculation in SPF-ECEs and − 1.161 (50%, RBCs) and − 1.403 (75%, RBCs) following SPF-ECE inoculation. Compared to ECEs inoculated with NDV alone, the α-sitosterol-treated group showed improvement in histological lesion ratings for chorioallantoic membranes (CAM) and hepatic tissues. The CAM of the α-sitosterol- inoculated SPF-ECEs was preserved. The epithelial and stromal layers were noticeably thicker with extensive hemorrhages, clogged vasculatures, and certain inflammatory cells in the stroma layer in the NDV group. However, mild edema and inflammatory cell infiltration were observed in the CAM of the treated group. ECEs inoculated with α-sitosterol alone showed normal histology of the hepatic acini, central veins, and portal triads. Severe degenerative alterations, including steatosis, clogged sinusoids, and central veins, were observed in ECEs inoculated with NDV. Mild hepatic degenerative alterations, with perivascular round cell infiltration, were observed in the treated group. Conclusion: To the best of our knowledge, this is the first study to highlight that the potentially bioactive secondary metabolite, α-sitosterol, belonging to the terpene family, has the potential to be a biological weapon against virulent NDV. It could be used for the development of innovative antiviral drugs to control NDV after further clinical investigation.


  • Open Access

    Copper chitosan nanocomposite as antiviral and immune-modulating effect in broiler experimentally infected with chicken anemia virus

    by Dalia M. Elmasry, Mai A. Fadel, Farida H. Mohamed, Asmaa M. Badawy, Hanaa H. Elsamadony

    In the last few years, inorganic nanosystems, or nanometals, were of great interest to conventional therapy. In this study, Copper Chitosan Nanocomposite (CuCNP) was monitored for its antiviral, immune-stimulant, and lowering agent of Cu residue roles by using Chicken Anemia Virus (CAV) as a model. CuCNP is a metallic oxide nanocomposite with specific properties, such as sphere shape, no aggregation, and narrow size distribution 24.71±1.68 nm PdI: 0.691±0.02. We grouped 100 broiler chicks into four groups. Group 1 served as a regular negative control group. In drinking water, G2 was treated with CuCNP 1 mg/ml for five days. The G3 was infected with 0.2 ml I/M of CAV strain (MN339532) at one day old with CuCNP 1 mg/ml in drinking water for five days. G4 virus-positive control group with viral 3.987×106 virus copies/ml. Different serum and organ tissue homogenate samples were collected at different time intervals to measure residues, CAV viral concentration in organs, and serum to monitor cellular and humoral immunity. The excellent results of CuCNP are improving the innate immune response phagocytic activity, lysozyme, and NO, also cytokine levels mRNA of IFN-γ, IL-6, and IL-10 in G2 and G3 and elevating CAV antibody titers with decreases the CAV viral load in organs with a noticeable decrease of its residues in G2 and G3. The current study provides evidence of the immunostimulatory effect of CuCNP on CAV infection. It clarifies a constant reduction of CuCNP residues in broilers muscle and liver tissues, keeping its levels below Cu maximum residual limits (MRLs).


  • Open Access

    Characterization of a multifunctional biocontrol agent, Streptomyces Misakimycin, against Newcastle Disease Virus

    by Rewan Abdelaziz, Ahmed B. Barakat, Gamal El-Didamony, Yasmine H. Tartor, Marwa M. Gado, Hanaa A. El-Samadony

    Background The Newcastle Disease Virus (NDV) is present throughout the world, and outbreaks in Egypt caused serious economic losses in the poultry industry. Actinobacteria are a phylum of bacteria known for their potential in producing structurally diversified natural products which promising natural compounds used to combat viruses are presented and evaluated. Streptomyces Misakimycin isolated from Egyptian soil, and evaluated for their efficacy in controlling NDV. On the basis of the biochemical characteristics S. Misakimycin metabolites, identified by infrared (IR) and nuclear magnetic resonance (NMR) spectroscopy. Results In this investigation, NDV was found to have been isolated in February from a chicken farm in the Dakahlia Governorate of Egypt by the Animal Health Research Institute in Dokki, Giza. Diethylpthalate (DEP), a secondary metabolite of S. misakimycin, completely inhibited the hemagglutination (HI) activity of the NDV strain (MN635617) at log107 infectivity titers (EID50/mL). With 0.5 percent and 0.75 percent of chicken RBCs, the HA of the NDV strain was 2 log2 and 5 log2, respectively. In the treated group that received DEP and NDV inoculations, chorioallantoic-membranes (CAM) structures were preserved along with dilated capillary networks. Histological changes in SPF-ECE liver were examined after inoculation in ova to further characterize the DEP effect. Diethylpthalate and NDV mixture inoculated group showed preserved cytoarchitecture of hepatocytes with the presence of perivascular foci of lymphocytes. The group that was inoculated with telomycin alone showed normal histology of hepatic acini, central veins, and portal triads. Conclusion A potentially bioactive substance called diethylpthalate has the potential to be a biological weapon against a fatal chicken NDV that quickly increase cost losses for farmers.


  • Open Access

    Streptomyces coeruleorubidus as a potential biocontrol agent for Newcastle disease virus

    by Rewan Abdelaziz, Yasmine H. Tartor, Ahmed B. Barakat, Gamal El-Didamony, Hanaa A. El-Samadony, Shimaa A. Amer, Marwa M. Gado

    Background: Newcastle disease virus (NDV) is a severe disease that affects domestic and wild birds. Controlled antibiotics derived from probiotics have been examined as prospective solutions for preserving seroconversion in NDV-vaccinated fowl. In this study, the secondary metabolite “telomycin” was extracted from Streptomyces coeruleorubidus (S. coeruleorubidus) isolated from Egypt's cultivated soil. The structure of telomycin was determined by the elucidation of spectroscopic analysis, including nuclear magnetic resonance (NMR) and mass spectrometry (MS) spectra, and comparison with the literature. The antiviral activity of the secondary metabolite was tested by checking its effect on NDV hemagglutination activity (HA). Moreover, HA of NDV was tested after inoculation of NDV (control) and a combination of telomycin and NDV in 10- days- specific pathogen-free embryonated chicken eggs (SPF-ECE) daily candling. Histopathological examination was performed for chorioallantoic membranes and liver of SPF-ECE. Results: S. coeruleorubidus secondary metabolite “telomycin” showed complete hemagglutination inhibition (HI) activity of NDV strain (MN635617) with log106 infectivity titers (EID50/mL). The HA of NDV strain was 8 log2 and 9 log2 with 0.5% and 0.75% of chicken RBCs, respectively. Preserved structures of chorioallantoic-membranes (CAM) with dilated capillary networks were observed in the treated group inoculated with telomycin and NDV. Histological changes in SPF-ECE liver were examined after inoculation in ova to further characterize the telomycin effect. Telomycin and NDV mixture inoculated group showed preserved cytoarchitecture of hepatocytes with the presence of perivascular foci of lymphocytes. The group that was inoculated with telomycin alone showed normal histology of hepatic acini, central veins, and portal triads. Conclusion: S. coeruleorubidus telomycin is a promising bioactive agent that might be a biological weapon against a deadly chicken NDV that costs farmers a lot of money.


  • Open Access

    Development and validation of UV chromatographic method for quantification of copper and copper nanoparticles in different matrices and pharmaceutical products

    by Mai A. Fadel, Dalia M. A. Elmasry, Farida H. Mohamed, Asmaa M. Badawy, Hanaa A. Elsamadony

    Background: The applications of Cu and CuNPs based on the earth-abundant and inexpensive Cu metal have generated a great deal of interest in recent years, including medical applications. A novel, specific, precise, accurate and sensitive reverse-phase high-performance liquid chromatography (RP-HPLC) method with UV detection has been developed and validated to quantify copper (Cu) and copper nanoparticles (CuNPs) in different biological matrices and pharmaceutical products. Methods: The developed method has been validated for linearity, precision, sensitivity, specificity and accuracy. Cu concentration was detected in pharmaceutical products without an extraction process. Moreover, liver, serum and muscle tissues were used as biological matrices. High Cu recovery in biological samples was afforded by using citric acid as a green chelating agent, exact extraction time and pH adjustment. Cu pharmaceutical and biological samples were eluted by acetonitrile: ammonium acetate (50 mM) with 0.5 mg/ml EDTA (30:70 v:v) as an isocratic mobile phase. EDTA reacted with Cu ions forming a Cu-EDTA coloured complex, separated through the C18 column and detected by UV at 310 nm. Results: The developed method was specific with a short retention time of 4.95 min. It achieved high recovery from 100.3% to 109.9% in pharmaceutical samples and 96.8–105.7% in biological samples. The precision RSD percentage was less than two. The method was sensitive by achieving low detection limits (DL) and quantification limits (QL). Conclusion: The validated method was efficient and economical for detecting Cu and CuNPs by readily available chemicals as EDTA and Citric acid with C18 column, which present the best results on RP-HPLC.

  • Pathogenesis Of Two Chicken Infectious Anaemia Virus (CIAV) Vaccines In Lymphoid and Non-lymphoid Organs

    by Heba Ali AbdAlla, Laila Abd El Ghani Tantawy, Hussein Ali Hussein, Hanaa Awad Elsamadony, Nabiha Ramadan Ali Hassan

    CIAV is one of the most important ubiquitous immunosuppressive pathogen in chicken, which leads to great economic loss in poultry industry worldwide. Here we experimentally investigated the pathogenesis of two live-attenuated CIAV vaccines. One-hundred-twenty-five, 1-day-old specific-pathogen-free (SPF) chicks were allocated into five-groups (25-chicks-each). Group-1 was orally vaccinated with attenuated CIAV vaccine-strain in drinking water. Group-2 was kept as a contact non-vaccinated-group to group-1. Group-3 was intramuscularly vaccinated with attenuated CIAV vaccine-strain. Group-4 was kept as a contact-non-vaccinated-group to group-3, and group-5 served as a control group. Three-chickens from each group were sacrificed at 3rd, 7th, 15th, 22nd, 29th, 36th and 41st days-post-vaccination (dpv). Tissue specimens from bone-marrow, thymus, spleen, cecal-tonsils, bursa-of-Fabricius and liver were collected for histopathology, lesion-scoring and immunohistochemistry fluorescence detection of CIAV-antigen. Liver-specimens were also collected at 7th, 15th, 21st dpv for real-time-PCR (qPCR), to quantitate the CAV genomic-DNA. Mortalities occurred in both vaccinated groups and their contact groups. Group-4 had the highest no. of mortalities. Frothy diarrhea, ulcer, S/C-hemorrhages, cannibalism and signs of mild depression were the most developed clinical-signs in group1, 2, 3 and 4. Pale bone-marrow and atrophy of thymus were the most characteristic post-mortem changes in group 1, 2, 3 and 4. Microscopically, changes characteristic for CIAV were observed, and the most affected organs were bone-marrow, thymus, liver and spleen; respectively. The demonstrated histopathological lesions started as early as the 3rd dpv in almost all organ of concern in all 4-groups. Immunofluorescence labelling of CIAV-antigen demonstrates virus in all examined organs in both vaccinated and contact groups, with the bone-marrow as the strongest positive. CIAV-genome detected in livers of vaccinated and contact groups at concerned days. Indeed, live attenuated CIAV-vaccines (either by oral or parenteral route) are pathogenic to 1-day-old chicks and they could spread horizontally and transmitted to contact-chicks, inducing mortalities and immunosuppression.